Work

C7-04: Efficacy of BIBW 2992, a potent irreversible inhibitor of EGFR and HER2 in human NSCLC xenografts and in a transgenic mouse lung-cancer model

Year: 2007

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1097/01.jto.0000283232.53465.68

Authors: Takeshi Shimamura, Heidi Greulich, Flavio F. Solca, Kwok-Kin Wong

Institutions: Dana-Farber Cancer Institute, Broad Institute, Boehringer Ingelheim (Austria)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2048092750

FWCI: 0.521

Cites:

Cited by: 8

Related to: 10